IR@PKUHSC  > 北京大学第三临床医学院  > 泌尿外科
学科主题泌尿外科学
完全腹腔镜手术治疗肾细胞癌合并下腔静脉癌栓的临床分析
其他题名Clinical analysis of pure laparoscopic surgery for renal cell carcinoma with inferior vena cava tumor thrombus
王国良; 马潞林; 毕海; 侯小飞; 赵磊; 张树栋
关键词癌,肾细胞 下腔静脉癌栓 腹腔镜手术 Carcinoma,renal cell Inferior vena cava tumor thrombus Laparoscopic surgery
刊名中华泌尿外科杂志
2015
DOI10.3760/cma.j.issn.1000-6702.2015.09.005
36期:9页:653-656
收录类别中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型Journal Article
摘要目的 探讨完全腹腔镜手术治疗肾细胞癌合并下腔静脉癌栓的安全性和可行性.方法 回顾性分析2010年12月至2014年10月收治的6例采用完全腹腔镜手术治疗的肾细胞癌合并下腔静脉癌栓患者的临床资料.患者均为男性,年龄50 ~ 69岁.体质指数21.6 ~ 30.9 kg/m2.临床表现为无痛性肉眼血尿4例,腰痛1例,体检发现1例.影像学检查提示右肾占位4例,左肾占位2例,肿瘤最大径为4.0~10.6 cm.癌栓分级:Ⅰ级3例,Ⅱ级3例,其中Ⅱ级癌栓长度为4.0~4.2 cm.6例均采用完全腹腔镜下根治性肾切除+下腔静脉癌栓取出术,右肾占位者采用单纯后腹腔镜方式处理肾动脉及下腔静脉癌栓,左肾占位者采用后腹腔镜处理肾动脉,联合经腹腹腔镜处理下腔静脉癌栓.结果 本组6例手术均顺利完成,未发生癌栓脱落.手术时间224 ~ 873 min.术中失血量200~5 000 ml,4例输血,输悬浮红细胞400~2 800 ml.其中1例左肾癌合并Ⅱ级下腔静脉癌栓患者的手术时间为873 min,术中失血量5000 ml,输悬浮红细胞2 800 ml.术后住院时间7~14d.病理诊断均为肾透明细胞癌,Fuhrman分级Ⅱ~Ⅲ级.6例术后均采用靶向药物治疗.随访6~ 48个月,6例均无肿瘤复发和转移.结论 完全腹腔镜手术治疗右肾细胞癌合并下腔静脉癌栓以及左肾细胞癌合并Ⅰ级下腔静脉癌栓安全、可行;对于左肾细胞癌合并Ⅱ级下腔静脉癌栓,完全腹腔镜手术需要更长的学习曲线. Objective To assess the safety and feasibility of pure laparoscopic surgery for renal cell carcinoma with inferior vena cava tumor thrombus.Methods We retrospectively analyzed 6 cases of renal cell carcinoma with inferior vena cava tumor thrombus from December 2010 to October 2014.The patients were all male.Their age ranged from 50 to 69 years and the body mass index ranged from 21.6 to 30.9 kg/ m2.Clinical manifestations included painless hematuria in 4 cases,low back pain in 1 cases and physical examination noticing in 1 cases.Imaging suggested the right renal tumor in 4 cases and left renal tumor in 2 cases.The tumor size ranged from 4.0 to 10.6 cm.The inferior vena cava tumor thrombus was found in all patients,including type Ⅰ thrombus in 3 cases and type Ⅱ thrombus in 3 cases.The length of type Ⅱ tumor thrombus ranged from 4.0 to 4.2 cm.We completed pure laparoscopic nephrectomy and inferior vena cava tumor thrombectomy in all patients.We chose retroperitoneal laparoscopic surgery to treat right renal tumor with inferior vena cava thrombus and chose retroperitoneal combined with transperitoneal laparoscopic surgery to treat left renal tumor with inferior vena cava thrombus.Results All surgery were successful.Cancer embolus defluxion didn't occur during the opearation.The operation time was 224-873 min and the intraoperative blood loss was 200-5 000 ml.There were 4 patients get transfusion,which the transfusion volume ranged from 400 to 2 800 ml.For 1 case of left renal cell carcinoma with level Ⅱ inferior vena cava tumor,the operation time was 873 min,the blood loss was 5 000 ml,and the transfusion volume was 2 800 ml.Postoperative hospital stay was 7-14 days.And the pathological results were all renal clear cell carcinoma.In those patients,the Fuhrman grade classification was Ⅱ-Ⅲ.All patients were treated by targeted medicine to control tumor recurrence and metastasis.During the 6-48 months following up,no recurrence and metastasis were reported.Conclusions Pure laparoscopic surgery for right renal cell carcinoma with inferior vena cava tumor thrombus and left renal cell carcinoma with level Ⅰ inferior vena cava tumor thrombus is safe and feasible.However,long learning curve should be necessary for performing the left renal cell carcinoma with level Ⅱ inferior vena cava tumor thrombus.The effect of total laparoscopic surgery for renal cell carcinoma with inferior vena cava tumor thrombus is definite.
语种中文
原文出处查看原文
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/72418
专题北京大学第三临床医学院_泌尿外科
作者单位100191,北京大学第三医院泌尿外科
推荐引用方式
GB/T 7714
王国良,马潞林,毕海,等. 完全腹腔镜手术治疗肾细胞癌合并下腔静脉癌栓的临床分析[J]. 中华泌尿外科杂志,2015,36(9):653-656.
APA 王国良,马潞林,毕海,侯小飞,赵磊,&张树栋.(2015).完全腹腔镜手术治疗肾细胞癌合并下腔静脉癌栓的临床分析.中华泌尿外科杂志,36(9),653-656.
MLA 王国良,et al."完全腹腔镜手术治疗肾细胞癌合并下腔静脉癌栓的临床分析".中华泌尿外科杂志 36.9(2015):653-656.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[王国良]的文章
[马潞林]的文章
[毕海]的文章
百度学术
百度学术中相似的文章
[王国良]的文章
[马潞林]的文章
[毕海]的文章
必应学术
必应学术中相似的文章
[王国良]的文章
[马潞林]的文章
[毕海]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。